2026-W46 · Nov 9–Nov 15 · Company · Profile · published
Henry Schein company profile · dental and medical distribution, specialty products and practice technology · history · financial snapshot · S&P 500 rank #493 · 亨利薛恩公司業務歷史財務與標普500地位
SNAPSHOT
| Ticker | HSIC (Nasdaq) |
| Company | Henry Schein, Inc. |
| GICS sector / industry | Health Care / Health Care Distributors |
| S&P 500 rank (by weight) | #493 · 0.01% (Nov 5, 2026) |
| Sector rank (by S&P 500 weight) | #60 in Health Care (Nov 5, 2026) |
| Headquarters | Melville, New York |
| Founded | 1932, founded by Henry Schein in Queens, New York |
| CEO | Frederick M. Lowery (CEO, from 2026; succeeded Stanley M. Bergman) |
| Employees | >25,000 employees (FY2025 10-K) |
| Market cap | $9.83B (Nov 5, 2026) |
| SEC filings | EDGAR — CIK 0001000228 |
WHAT IT DOES
Henry Schein, Inc. is the world’s largest provider of health care solutions to office-based dental and medical practitioners. It distributes consumable products, equipment and pharmaceuticals to more than 1 million customers in over 30 countries, and layers higher-margin specialty products, practice-management software and value-added services on top of the distribution base. The model is a one-stop catalogue: practices order merchandise, equipment, software and services from a single supplier with next-day logistics.
FY2025 net sales were $13.18B, up 4.0% year on year, and net income attributable to Henry Schein, Inc. was $398M, or $3.27 per diluted share, against $390M, or $3.05, in FY2024. Operating income was $653M. The sales increase reflected 2.6% internal growth, 0.9% from acquisitions and a 0.5% foreign-currency benefit, per the company’s FY2025 results release.
Henry Schein reports three segments: Global Distribution and Value-Added Services (the merchandise, equipment and services engine), Global Specialty Products (own-manufactured and sourced specialty lines such as dental implants, biomaterials and orthopedics) and Global Technology (practice-management software, e-services and revenue-cycle tools). Specialty and technology carry structurally higher margins than distribution, so mix shift toward them is the profit lever.
SEGMENTS — FY2025 NET SALES
| Segment | Net sales | Share | YoY |
|---|---|---|---|
| Global Distribution and Value-Added Services | $11.14B | 84.5% | +3.5% |
| Global Specialty Products | $1.54B | 11.7% | +6.8% |
| Global Technology | $675M | 5.1% | +7.1% |
| Eliminations | −$173M | −1.3% | — |
HISTORY
| Year | Milestone |
|---|---|
| 1932 | Henry Schein, a Columbia pharmacy graduate, borrows $500 and opens a pharmacy in Queens, New York — the origin of the company. |
| 1989 | Stanley M. Bergman becomes CEO after the death of Jay Schein; he leads the company for more than three decades. |
| 1995 | Henry Schein completes its initial public offering and lists on Nasdaq. |
| 2026 | Frederick M. Lowery succeeds Stanley M. Bergman as CEO (announced in January 2026, after Bergman’s July 2025 announcement that he would step down at the end of 2025 and remain chairman). |
COMPETITIVE POSITION
FINANCIAL SNAPSHOT — FY2025
| Net sales | $13.18B |
| Operating income | $653M |
| Net income attributable to Henry Schein, Inc. | $398M |
| Diluted EPS | $3.27 |
KEY RISKS
WHY IT MATTERS FOR THE S&P 500
Henry Schein is the S&P 500’s dental-and-medical distribution bellwether: its internal sales growth, specialty mix and practice-technology adoption read as a gauge of office-based health care spending in the U.S. and Europe. At rank #493 by weight (0.01%) — Health Care #60 — it represents the distributor inside a health care sector dominated by insurers, pharmaceuticals and device makers.
SOURCES & METHODOLOGY
| Market data | Slickcharts S&P 500 by weight (rank, weight, price, market cap — Nov 5, 2026 crawl, single source) |
| Financials | Form 10-K for FY2025 (fiscal year ended Dec 27, 2025) |
| Sector classification | GICS via the List of S&P 500 companies (Wikipedia) |
| Library data | SPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information. |
Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com
FINANCIALS
公司快照
| 股票代號 | HSIC(Nasdaq) |
| 公司 | Henry Schein, Inc. |
| GICS 板塊/行業 | 醫療保健/Health Care Distributors |
| 標普500排名(按權重) | 第493名 · 0.01%(2026 年 11 月 5 日) |
| 板塊內排名(按標普500權重) | 醫療保健第60名(2026 年 11 月 5 日) |
| 總部 | 紐約州梅爾維爾 |
| 成立 | 1932年,由 Henry Schein 於紐約州皇后區創立 |
| 行政總裁 | Frederick M. Lowery(行政總裁,自2026年起;接替 Stanley M. Bergman) |
| 員工 | 超過25,000名員工(FY2025 10-K) |
| 市值 | $9.83B(2026 年 11 月 5 日) |
| SEC 文件 | EDGAR — CIK 0001000228 |
業務概覽
亨利薛恩公司是全球最大的以診所為基礎的牙科及醫療從業員醫療保健方案供應商。它向30多個國家逾100萬名客戶分銷消耗品、設備及藥品,並在分銷基礎之上疊加利潤較高的專門產品、診所管理軟件及增值服務。其模式是一站式目錄:診所可向單一供應商訂購用品、設備、軟件及服務,並享有翌日物流。
FY2025 淨銷售額為131.8億美元,同比增長4.0%;歸屬於亨利薛恩公司的淨利潤為3.98億美元,攤薄每股收益3.27美元,而 FY2024 為3.90億美元,攤薄每股收益3.05美元。營運利潤為6.53億美元。據公司 FY2025 業績公告,銷售增長來自2.6%的內部增長、0.9%的收購貢獻及0.5%的外匯利好。
亨利薛恩報告三個板塊:全球分銷及增值服務(用品、設備及服務引擎)、全球專門產品(自家製造及採購的專門產品線,如牙科植入物、生物材料及骨科產品)及全球科技(診所管理軟件、電子服務及收入週期工具)。專門產品及科技的利潤率結構上高於分銷,故組合向兩者傾斜是利潤槓桿。
板塊 — FY2025 淨銷售額
| 板塊 | 淨銷售額 | 佔比 | 同比 |
|---|---|---|---|
| 全球分銷及增值服務 | 111.4億美元 | 84.5% | +3.5% |
| 全球專門產品 | 15.4億美元 | 11.7% | +6.8% |
| 全球科技 | 6.75億美元 | 5.1% | +7.1% |
| 抵銷 | −1.73億美元 | −1.3% | — |
歷史沿革
| 年份 | 里程碑 |
|---|---|
| 1932年 | Henry Schein(哥倫比亞大學藥劑學畢業生)借入500美元,在紐約州皇后區開設藥房——公司的起源。 |
| 1989年 | Jay Schein 逝世後,Stanley M. Bergman 出任行政總裁,領導公司逾三十年。 |
| 1995年 | 亨利薛恩完成首次公開發售,於納斯達克上市。 |
| 2026年 | Frederick M. Lowery 接替 Stanley M. Bergman 出任行政總裁(2026年1月公布;Bergman 於2025年7月已宣布將於2025年底卸任並留任主席)。 |
競爭地位
財務快照 — FY2025
| 淨銷售額 | 131.8億美元 |
| 營運利潤 | 6.53億美元 |
| 歸屬於亨利薛恩公司的淨利潤 | 3.98億美元 |
| 攤薄每股收益 | 3.27美元 |
主要風險
對標普500的重要性
亨利薛恩是標普500中牙科及醫療分銷的風向標:其內部銷售增長、專門產品組合及診所科技採用情況,可反映美國及歐洲以診所為基礎的醫療開支。按權重排名第493位(0.01%)——醫療保健第60名——它代表醫療保健板塊內的分銷商,而該板塊由保險公司、藥廠及醫療器械商主導。
來源與方法
| 市場數據 | Slickcharts 標普500權重榜(排名、權重、價格、市值——2026 年 11 月 5 日抓取,單一來源) |
| 財務 | FY2025 10-K(截至2025年12月27日的財政年度) |
| 板塊分類 | GICS,據 S&P 500 公司清單(Wikipedia) |
| 圖庫數據 | SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。 |
來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份)· SPXSet.com
財報
SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。
Entered 2026-11-04 16:59 · updated 2026-11-14 23:30 · rev 6